VHI trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes VHI achieves its forward estimates and maintains a stable P/E multiple of 4.7x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Valhi, Inc. (VHI) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $462M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Sell, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, VHI trades at a trailing P/E of -8.1x and forward P/E of 4.7x. Analysts expect EPS to grow +360.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $3.77, with bear and bull scenarios of $2.37 and $4.97 respectively. Model confidence stands at 37/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 KROKronos Worldwide, Inc. | $970M | $8.43 | $8.50 | +0.8% | Hold | 21.1x | 7 |
 HUNHuntsman Corporation | $1.6B | $9.10 | $12.29 | +35.1% | Hold | — | 33 |
 CCThe Chemours Company | $2.2B | $14.74 | $21.88 | +48.4% | Hold | 14.6x | 20 |
 NLNLI Holdings, Inc. | $339M | $6.94 | $6.00 | -13.5% | Sell | 8.0x | 1 |
 COMPCompass, Inc. | $5.6B | $9.16 | $13.93 | +52.1% | Buy | 49.5x | 11 |
 TROXTronox Holdings plc | $686M | $4.30 | $8.08 | +87.9% | Buy | — | 17 |
 BCPCBalchem Corp | $5.4B | $168.24 | $215.00 | +27.8% | Buy | 31.1x | 10 |
 IOSPInnospec Inc. | $2.4B | $96.60 | $110.00 | +13.9% | Hold | 19.6x | 9 |
 RTXRTX Corporation | $259.0B | $192.19 | $238.50 | +24.1% | Buy | 26.5x | 26 |
 LMTLockheed Martin Corporation | $121.1B | $524.68 | $644.86 | +22.9% | Buy | 17.2x | 37 |
Quick answers to the most common questions about buying VHI stock.
The consensus price target for VHI is $N/A, close to the current price of $16.33 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
VHI has a consensus rating of "Sell" based on 1 Wall Street analysts. The rating breakdown is leaning bearish, with 1 Sell/Strong Sell ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 4.7061x, VHI trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for VHI, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $5 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
VHI is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month VHI stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Sell". Our proprietary valuation model produces a base case fair value of $4, with bear/bull scenarios of $2/$5.
Our quantitative valuation model calculates VHI's fair value at $4 (base case), with a bear case of $2 and bull case of $5. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 37/100.
VHI trades at a forward P/E ratio of 4.7x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
VHI appears fairly valued according to analysts, with a "Sell" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
VHI analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $2-$5 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.